Cue Biopharma, Inc. Profile Avatar - Palmy Investing

Cue Biopharma, Inc.

Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate i…

Biotechnology
US, Cambridge [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of CUE's Analysis
CIK: 1645460 CUSIP: 22978P106 ISIN: US22978P1066 LEI: - UEI: -
Secondary Listings
CUE has no secondary listings inside our databases.